Monika Roy, MD

Email Monika
(415) 476-4082 x341

1001 Potrero Ave
San Francisco, CA 94110

Visit CTSI Profile

Email Monika
(415) 476-4082 x341

1001 Potrero Ave
San Francisco, CA 94110

Visit CTSI Profile

  • Assistant Professor, UCSF School of Medicine
  • Assistant Professor, UCSF School of Medicine

Biography

Dr. Monika Roy is an assistant professor in the Division of HIV, Infectious Diseases, and Global Medicine at Zuckerberg San Francisco General Hospital (ZSFG). Her research focuses on the application of implementation science methodology to advance effective, efficient, and sustainable treatment of chronic diseases in resource-limited settings. Her research currently centers around evaluation of community-based HIV care and treatment strategies in sub-Saharan Africa and the translation of lessons learned in the global HIV response to the treatment of non-communicable diseases such as hypertension. She is also a clinical provider within the Positive Health Practice "Ward 86" at ZSFG, which is the first and largest clinic in San Francisco dedicated to providing multidisciplinary care for HIV-positive patients.

Biography

Dr. Monika Roy is an assistant professor in the Division of HIV, Infectious Diseases, and Global Medicine at Zuckerberg San Francisco General Hospital (ZSFG). Her research focuses on the application of implementation science methodology to advance effective, efficient, and sustainable treatment of chronic diseases in resource-limited settings. Her research currently centers around evaluation of community-based HIV care and treatment strategies in sub-Saharan Africa and the translation of lessons learned in the global HIV response to the treatment of non-communicable diseases such as hypertension. She is also a clinical provider within the Positive Health Practice "Ward 86" at ZSFG, which is the first and largest clinic in San Francisco dedicated to providing multidisciplinary care for HIV-positive patients.

Displaying 1 - 34 of 34

  1. Samayoa B, Roy M, Cleveland AA, Medina N, Lau-Bonilla D, Scheel CM, Gomez BL, Chiller T, Arathoon E. High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala. Am J Trop Med Hyg. 2017 Jul; 97(1):42-48. View on Pubmed
  2. Roy M, Muyindike W, Vijayan T, Kanyesigye M, Bwana M, Wenger M, Martin J, Geng E. Implementation and Operational Research: Use of Symptom Screening and Sputum Microscopy Testing for Active Tuberculosis Case Detection Among HIV-Infected Patients in Real-World Clinical Practice in Uganda. J Acquir Immune Defic Syndr. 2016 Aug 15; 72(5):e86-91. View on Pubmed
  3. Roy M, Czaicki N, Holmes C, Chavan S, Tsitsi A, Odeny T, Sikazwe I, Padian N, Geng E. Understanding Sustained Retention in HIV/AIDS Care and Treatment: a Synthetic Review. Curr HIV/AIDS Rep. 2016 Jun; 13(3):177-85. View on Pubmed
  4. NP Govender, M Roy, JF Mendes, TG Zulu, TM Chiller, AS Karstaedt. Evaluation of a prospective screening programme for cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa. HIV Medicine. 2015; 16:468-476.
  5. Nacher M, Adenis A, Mc Donald S, Do Socorro Mendonca Gomes M, Singh S, Lopes Lima I, Malcher Leite R, Hermelijn S, Wongsokarijo M, Van Eer M, Marques Da Silva S, Mesquita Da Costa M, Silva M, Calvacante M, do Menino Jesus Silva Leitao T, Gómez BL, Restrepo A, Tobon A, Canteros CE, Aznar C, Blanchet D, Vantilcke V, Vautrin C, Boukhari R, Chiller T, Scheel C, Ahlquist A, Roy M, Lortholary O, Carme B, Couppié P, Vreden S. Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage. PLoS Negl Trop Dis. 2013 Nov; 7(11):e2319.
  6. Chiller TM, Roy M, Nguyen D, Guh A, Malani AN, Latham R, Peglow S, Kerkering T, Kaufman D, McFadden J, Collins J, Kainer M, Duwve J, Trump D, Blackmore C, Tan C, Cleveland AA, MacCannell T, Muehlenbachs A, Zaki SR, Brandt ME, Jernigan JA. Clinical findings for fungal infections caused by methylprednisolone injections. N Engl J Med. 2013 Oct 24; 369(17):1610-9.
  7. Roy M, Benedict K, Deak E, Kirby MA, McNiel JT, Sickler CJ, Eckardt E, Marx RK, Heffernan RT, Meece JK, Klein BS, Archer JR, Theurer J, Davis JP, Park BJ. A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering. Clin Infect Dis. 2013 Sep; 57(5):655-62.
  8. Loyse A, Thangaraj H, Easterbrook P, Ford N, Roy M, Chiller T, Govender N, Harrison TS, Bicanic T. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Lancet Infect Dis. 2013 Jul; 13(7):629-37.
  9. Fanfair RN, Heslop O, Etienne K, Rainford L, Roy M, Gade L, Peterson J, O'Connell H, Noble-Wang J, Balajee SA, Brandt ME, Lindo JF, Park BJ. Trichosporon asahii among intensive care unit patients at a medical center in Jamaica. Infect Control Hosp Epidemiol. 2013 Jun; 34(6):638-41.
  10. Kennedy ED, Roy M, Norris J, Fry AM, Kanzaria M, Blau DM, Shieh WJ, Zaki SR, Waller K, Kamimoto L, Finelli L, Jhung MA. Lower respiratory tract hemorrhage associated with 2009 pandemic influenza A (H1N1) virus infection. Influenza Other Respir Viruses. 2013 Sep; 7(5):761-5.
  11. Govender NP, Chetty V, Roy M, Chiller T, Oladoyinbo S, Maotoe T, Stevens WS, Pinini Z, Spencer D, Venter WD, Jassat W, Cameron D, Meintjes G, Mbengashe T, Pillay Y. Phased implementation of screening for cryptococcal disease in South Africa. S Afr Med J. 2012 Oct 08; 102(12):914-7.
  12. Roy M, Harris J, Afreen S, Deak E, Gade L, Balajee SA, Park B, Chiller T, Luby S. Aflatoxin contamination in food commodities in Bangladesh. Food Addit Contam Part B Surveill. 2013; 6(1):17-23.
  13. Klausner JD, Govender N, Oladoyinbo S, Roy M, Chiller T. Preventing AIDS deaths: cryptococcal antigen screening and treatment. Lancet Infect Dis. 2012 Jun; 12(6):431-2.
  14. Benedict K, Roy M, Chiller TM, Davis JP. Epidemiologic and ecologic features of blastomycosis: a review. Current Fungal Infections Report. 2012; (6):327-335.
  15. Roy M, Chiller T. Preventing deaths from cryptococcal meningitis: from bench to bedside. Expert Rev Anti Infect Ther. 2011 Sep; 9(9):715-7.
  16. Roy M, Chiller TM, . Preventing death from HIV-associated cryptococcal meningitis. Current Fungal Infections Report. 2011; (5):206-214.
  17. Roy M, Park BJ, Chiller TM. Donor-derived fungal infections in transplant patients. Current Fungal Infections Report. 2010; (4):219-228.
  18. Samayoa B, Roy M, Cleveland AA, Medina N, Lau-Bonilla D, Scheel CM, Gomez BL, Chiller T, Arathoon E. High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala. Am J Trop Med Hyg. 2017 Jul; 97(1):42-48. View on Pubmed
  19. Roy M, Muyindike W, Vijayan T, Kanyesigye M, Bwana M, Wenger M, Martin J, Geng E. Implementation and Operational Research: Use of Symptom Screening and Sputum Microscopy Testing for Active Tuberculosis Case Detection Among HIV-Infected Patients in Real-World Clinical Practice in Uganda. J Acquir Immune Defic Syndr. 2016 Aug 15; 72(5):e86-91. View on Pubmed
  20. Roy M, Czaicki N, Holmes C, Chavan S, Tsitsi A, Odeny T, Sikazwe I, Padian N, Geng E. Understanding Sustained Retention in HIV/AIDS Care and Treatment: a Synthetic Review. Curr HIV/AIDS Rep. 2016 Jun; 13(3):177-85. View on Pubmed
  21. NP Govender, M Roy, JF Mendes, TG Zulu, TM Chiller, AS Karstaedt. Evaluation of a prospective screening programme for cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa. HIV Medicine. 2015; 16:468-476.
  22. Nacher M, Adenis A, Mc Donald S, Do Socorro Mendonca Gomes M, Singh S, Lopes Lima I, Malcher Leite R, Hermelijn S, Wongsokarijo M, Van Eer M, Marques Da Silva S, Mesquita Da Costa M, Silva M, Calvacante M, do Menino Jesus Silva Leitao T, Gómez BL, Restrepo A, Tobon A, Canteros CE, Aznar C, Blanchet D, Vantilcke V, Vautrin C, Boukhari R, Chiller T, Scheel C, Ahlquist A, Roy M, Lortholary O, Carme B, Couppié P, Vreden S. Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage. PLoS Negl Trop Dis. 2013 Nov; 7(11):e2319.
  23. Chiller TM, Roy M, Nguyen D, Guh A, Malani AN, Latham R, Peglow S, Kerkering T, Kaufman D, McFadden J, Collins J, Kainer M, Duwve J, Trump D, Blackmore C, Tan C, Cleveland AA, MacCannell T, Muehlenbachs A, Zaki SR, Brandt ME, Jernigan JA. Clinical findings for fungal infections caused by methylprednisolone injections. N Engl J Med. 2013 Oct 24; 369(17):1610-9.
  24. Roy M, Benedict K, Deak E, Kirby MA, McNiel JT, Sickler CJ, Eckardt E, Marx RK, Heffernan RT, Meece JK, Klein BS, Archer JR, Theurer J, Davis JP, Park BJ. A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering. Clin Infect Dis. 2013 Sep; 57(5):655-62.
  25. Loyse A, Thangaraj H, Easterbrook P, Ford N, Roy M, Chiller T, Govender N, Harrison TS, Bicanic T. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Lancet Infect Dis. 2013 Jul; 13(7):629-37.
  26. Fanfair RN, Heslop O, Etienne K, Rainford L, Roy M, Gade L, Peterson J, O'Connell H, Noble-Wang J, Balajee SA, Brandt ME, Lindo JF, Park BJ. Trichosporon asahii among intensive care unit patients at a medical center in Jamaica. Infect Control Hosp Epidemiol. 2013 Jun; 34(6):638-41.
  27. Kennedy ED, Roy M, Norris J, Fry AM, Kanzaria M, Blau DM, Shieh WJ, Zaki SR, Waller K, Kamimoto L, Finelli L, Jhung MA. Lower respiratory tract hemorrhage associated with 2009 pandemic influenza A (H1N1) virus infection. Influenza Other Respir Viruses. 2013 Sep; 7(5):761-5.
  28. Govender NP, Chetty V, Roy M, Chiller T, Oladoyinbo S, Maotoe T, Stevens WS, Pinini Z, Spencer D, Venter WD, Jassat W, Cameron D, Meintjes G, Mbengashe T, Pillay Y. Phased implementation of screening for cryptococcal disease in South Africa. S Afr Med J. 2012 Oct 08; 102(12):914-7.
  29. Roy M, Harris J, Afreen S, Deak E, Gade L, Balajee SA, Park B, Chiller T, Luby S. Aflatoxin contamination in food commodities in Bangladesh. Food Addit Contam Part B Surveill. 2013; 6(1):17-23.
  30. Klausner JD, Govender N, Oladoyinbo S, Roy M, Chiller T. Preventing AIDS deaths: cryptococcal antigen screening and treatment. Lancet Infect Dis. 2012 Jun; 12(6):431-2.
  31. Benedict K, Roy M, Chiller TM, Davis JP. Epidemiologic and ecologic features of blastomycosis: a review. Current Fungal Infections Report. 2012; (6):327-335.
  32. Roy M, Chiller T. Preventing deaths from cryptococcal meningitis: from bench to bedside. Expert Rev Anti Infect Ther. 2011 Sep; 9(9):715-7.
  33. Roy M, Chiller TM, . Preventing death from HIV-associated cryptococcal meningitis. Current Fungal Infections Report. 2011; (5):206-214.
  34. Roy M, Park BJ, Chiller TM. Donor-derived fungal infections in transplant patients. Current Fungal Infections Report. 2010; (4):219-228.